Viewing Study NCT04756466



Ignite Creation Date: 2024-05-06 @ 3:47 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04756466
Status: COMPLETED
Last Update Posted: 2021-03-05
First Post: 2021-01-21

Brief Title: Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly
Sponsor: Biosearch SA
Organization: Biosearch SA

Study Overview

Official Title: Multicenter Randomized Double-blind Parallel Group Pilot Study to Evaluate the Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this trial is to evaluate the effect of the consumption of a probiotic strain on the incidence and severity of COVID-19 in elderly population living in a nursing home In addition it will be evaluated if the probiotic strain have some effect on the immune response generated by the Covid-19 vaccine inthis population
Detailed Description: The working hypothesis is that the administration of a Lactobacillus strain improves the immune response in the elderly population improving the immune response to a possible COVID-19 infection The strain would act as an adjuvant that contributes to developing an effective response against the virus and therefore there are fewer infectious symptoms due to this virus or if it appears it occurs in a milder way among the subjects who take the probiotic strain Alsothe investigators hypothesizes that the administration of the Lactobacillus may improve the immune response generated by the Covid-19 vaccine in this elderly population

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None